Sunandan Saha

Designation:
Scientist
Department:
Department of Medicine
University:
Bellicum Pharmaceuticals
Country:
USA
Email:
ssaha@bellicum.com
Journal Associated: International Journal of Immunotherapy and Cancer Research Biography:

Research Interest: My research interest involves finding innovative gene therapy solutions for human diseases. At Bellicum, Pharmaceuticals, I have played a leading role in the discovery and pre-clinical development of the CIDeCAR and Go-CART product portfolios. Prior to Bellicum, I was a trainee at Baylor College of Medicine where I developed a novel platform for delivery of erythropoietin to treat anemia associated with chronic kidney disease and evaluated the safety of the piggyBac gene delivery system for gene and cell the rapy. I have extensive research experience in immunotherapy of leukemias and solid tumors, adoptive transfer of T cells, T cell biology, tumor infiltrating lymphocytes, immune receptors biology, antigen processing and recognition, antibody therapy, tumor immunology, viral and non-viral vectors, and gene therapy of monogeneic disorders. I have comprehensive knowledge of molecular biology research techniques including genetic engineering, vector design, cloning, transfection platforms,

cytometry, biomarker development and validation and synthetic DNA construction 

Indexing/Archiving

Global Views

Case Reports

Peertechz Tweets

Google Reviews 11